je.st
news
Experts expect corporate tax inversions to survive new rules
2016-04-07 02:45:41| Biotech - Topix.net
In this Nov. 23, 2015, file photo, the Allergan logo appears above a trading post on the floor of the New York Stock Exchange. Allergan and Pfizer called off Wednesday, April 6, 2016, a record $160 billion merger after the Treasury issued new rules to make "tax inversions" less lucrative.
Tags: rules
corporate
tax
expect
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||